Bacterin (OTC:BONE) yesterday said it agreed to acquire spinal implant maker X-Spine Systems in a cash-and-stock deal worth about $86 million, including the assumption of debt, and rebrand as Xtant Medical Holdings. Belgrade, Mont.-based Bacterin, which makes allograft products using its in-house tissue bank, said the deal includes $60 million in cash, about 4.24 million Bacterin shares and […]
Bacterin International Holdings Inc.
FCC names new healthcare initiatives director | Personnel Moves
Xerox subsidiary ACS buys Breakaway Group | Acquisitions Roundup
Xerox (NYSE:XRX) subsidiary ACS acquired cloud-based electronic medical records program developer The Breakaway Group.
The Denver, Colo.-based firm developed PromisePoint, a program for training health care professionals to use electronic medical records systems the same way they would in a hospital or office.
Accuray ups offering to $100 million | Funding Roundup
Updated: 08/02/2011 1:30 p.m.
Accuray Inc. (NSDQ:ARAY) priced its proposed offering higher than previous estimates, coming in at $100 million in 3.75 percent convertible senior notes made available to institutional investors.
The sale was set to close yesterday, according to SEC filings.
Stock bulletin: Hedge fund billionaire bets big on Orthovita | Funding Roundup
Bacterin Q1 sales bound 120 percent | Earnings roundup
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Derma Sciences sales jump 16 percent | Earnings roundup
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Bacterin bounds from OTC to NYSE Amex | Funding roundup
Here’s a roundup of the latest dealflow and investment news:
Covidien wins 510(k) clearance for small jaw surgical tool | Regulatory roundup
Covidien plc (NYSE:COV) won 510(k) clearance for a new "small jaw" cutting and sealing surgical instrument.
The clearance adds another device to the Mansfield, Mass.-based medical products maker’s 12-year-old LigaSure line of surgical tools.
